CTC Clinical Trial Consultants AB

The research at CTC Clinical Trial Consultants AB emphasizes conditions such as obesity and overweight, seeking to test new therapies that support weight reduction and improve metabolic health.

• Appetite regulation strategies
• Energy balance and metabolic rate studies
• Pharmacokinetic profiling of weight‑loss agents
• Safety and tolerability in metabolic cohorts

Across five early‑phase trials, a team of twenty investigators in Uppsala is advancing therapeutic options for metabolic disease.

The program focuses on chronic lung illnesses like chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis, evaluating innovative treatments to preserve lung function and enhance patient quality of life.

• Inhaled drug delivery platforms
• Anti‑fibrotic therapeutic candidates
• Biomarker development for disease progression
• Safety assessments in pulmonary populations

With five active studies and twenty researchers, the Uppsala‑based site is driving forward new therapeutic strategies for respiratory health.